On June 17, 2025, SELLAS Life Sciences held its Annual Meeting where stockholders re-elected directors and approved several proposals including a 800,000-share increase to the Employee Stock Purchase Plan. About 64.85% of shares were represented, and various votes on executive compensation and proxy solicitation were also conducted.